PAREXEL RECIST 1.1
By PAREXEL International Corporation
This app is only available on the App Store for iOS devices.
Learn about RECIST 1.1 and how it can be applied to your clinical trial.
RECIST (Response Evaluation Criteria In Solid Tumors) is a set of published rules that define when cancer patients improve ("respond"), stay the same ("stable") or worsen ("progression") during treatments.
What's New in Version 2.0.1
Improved RECIST calculations which includes percent changes from Nadir.
User can enter Baseline and up to 9 follow up time points.
Target lesion measurements can be designated as lymph nodes.
- Category: Medical
- Updated: 16 May 2016
- Version: 2.0.1
- Size: 8.0 MB
- Language: English
- Developer: PAREXEL International Corporation
- © PAREXEL Informatics
Compatibility: Requires iOS 8.0 or later. Compatible with iPhone 5s, iPhone 6, iPhone 6 Plus, iPhone 6s, iPhone 6s Plus, iPhone SE, iPhone 7, iPhone 7 Plus, iPhone 8, iPhone 8 Plus, iPhone X, iPad Air, iPad Air Wi-Fi + Cellular, iPad mini 2, iPad mini 2 Wi-Fi + Cellular, iPad Air 2, iPad Air 2 Wi-Fi + Cellular, iPad mini 3, iPad mini 3 Wi-Fi + Cellular, iPad mini 4, iPad mini 4 Wi-Fi + Cellular, 12.9-inch iPad Pro, 12.9-inch iPad Pro Wi-Fi + Cellular, 9.7-inch iPad Pro, 9.7-inch iPad Pro Wi-Fi + Cellular, iPad Wi-Fi (5th generation), iPad Wi-Fi + Cellular (5th generation), 12.9-inch iPad Pro (2nd generation), 12.9-inch iPad Pro Wi‑Fi + Cellular (2nd generation), 10.5-inch iPad Pro, 10.5-inch iPad Pro Wi‑Fi + Cellular and iPod touch (6th generation).